Based on our European Physician & Payer Forum report entitled Will Emerging Monoclonal Antibodies Threaten MabThera’s Domination of the Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Markets in Europe? Clinician and Payer Perspectives, Decision Resources is offering an exclusive webinar entitled European Clinician and Payer Perspectives on the Dominance of Roche’s MabThera in NHL and CLL – Will Emerging Monoclonal Antibodies Be Able to Compete? Because this webinar will feature major report findings, it is ONLY available to purchasers of this report. This webinar will be held on September 22, 2010. Contact us to learn how you can purchase this Physician & Payer Forum report and attend this event. Click here to view the invite.
Based on our Physician & Payer Forum report entitled Physician and Payer Attitudes Towards Effient, Brilinta and Other Novel Oral Antiplatelets for ACS and CHD, Decision Resources is offering an exclusive webinar entitled Will Effient, Brilinta and Other Novel Oral Antiplatelets Gain Widespread Physician and Payer Acceptance in ACS and CHD? Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on August 11, 2010. Contact us to learn how you can purchase this Physician & Payer Forum report and access a recorded playback of this event. Click here to view the invite.
Based on our Physician & Payer Forum report entitled Hepatitis C: Reimbursement and Uptake of Novel Antivirals Among Payers and Prescribers, Decision Resources is offering an exclusive webinar entitled How Will Clinicians and Pharmacy Directors Respond to the Increasing Number of Treatment Options for Hepatitis C Virus? Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on July 28, 2010. Contact us to learn how you can purchase this Physician & Payer Forum report and access a recorded playback of this event. Click here to view the invite.
Based on our Physician & Payer Forum report entitled Pulmonary Arterial Hypertension: How Will Physicians and Payers Shape an Evolving Market? Decision Resources is offering an exclusive webinar entitled The Impact of Physician Prescribing Habits and Payer Reimbursement on the Pulmonary Arterial Hypertension Drug Market. Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on June 30, 2010. Contact us to learn how you can purchase this Physician & Payer Forum report and access a recorded playback of this event. Click here to view the invite.
As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive webinar entitled How Will News of Teva’s Early Stage Trials of Biosimilar Rituximab Alter Expectations for Complex Biosimilars? This webinar is open ONLY to subscribers of Decision Resources’ new Biosimilars Advisory Service. This webinar was held on June 23, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event. Click here to view the invite.
Decision Resources is offering a Pharmaview competitive assessment entitled News from ASCO: The Ongoing Push to Move Away From a ‘One Drug Treats All’ Approach in Cancer Treatment. This webinar was held on June 22, 2010. Contact us to learn how you can become a Pharmaview subscriber and access a recorded playback of this event. Click here to view the invite.
Based on our Physician & Payer Forum report entitled Biologics and Formulations for Inflammatory and Nociceptive Pain: Will These Agents Gain Widespread Physician and Payer Acceptance Despite a Crowded Market?, Decision Resources is offering an exclusive webinar entitled Inflammatory and Nociceptive Pain: Physician and Payer Insights Regarding the First-in-Class Biologic Analgesic, Tanezumab. Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on June 16, 2010. Contact us to learn how can purchase this Physician & Payer Forum report and access a recorded playback of this event. Click here to view the invite.
Decision Resources is offering an exclusive Pharmaview competitive assessment entitled Astellas and OSI: Major Japanese Pharma Companies Continue to Upgrade Their U.S. Presence and Oncology Portfolios. This session is ONLY available to Pharmaview subscribers. This webinar was held on June 3, 2010. Contact us to learn how you can become a Pharmaview subscriber and access a recorded playback of this event. Click here to view the invite.
Based on our Physician & Payer Forum report entitled Physician and Payer Acceptance of Emerging Fixed-Dose Combination Inhalers for Asthma and COPD, Decision Resources is offering an exclusive webinar entitled Physician and Payer Perspectives on Emerging LABA/ICS Combinations in Asthma and COPD – Will New Treatments Differentiate Themselves from Advair and Symbicort? Because this webinar features major report findings, it is ONLY available to purchasers of this report. This webinar was held on May 26, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event. Click here to view the invite.
Based on the new numbers from Pharmaview, Decision Resources hosted a webinar entitled Pharmaceutical Industry Outlook: Predictions for the Next 7 Years. This webinar shares the insight you need to understand how the pharmaceutical industry will evolve in the next 7 years. This webinar was held on May 12, 2010. Contact us to learn how you can become a Pharmaview subscriber and access a recorded playback of this event. Click here to view the invite.